Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simple in vitro method to characterize antiarrhythmic agents.

A M Hackett1, S J McDonald, P Schneider

  • 1Department of Cardiovascular Research, G. D. Searle and Co., Skokie, Illinois.

Journal of Pharmacological Methods
|April 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computer experiments to determine whether over- or under-counting necessarily affects the determination of difference in cell number between experimental groups.

Journal of neuroscience methods·2001
Same author

Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.

Pharmacological research·2000
Same author

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

The Journal of experimental medicine·1999
Same author

Time requirements in conformal radiotherapy treatment planning.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·1999
Same author

Brain soluble fractions which modulate Na+, K+-ATPase activity likewise modify muscarinic receptor.

Neurochemical research·1999
Same author

Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma.

Annals of hematology·1999

A novel in vitro method effectively identifies antiarrhythmic agents by measuring effects on developed tension, excitability, and effective refractory period in guinea pig papillary muscles. This approach aids in characterizing potential new drugs for cardiac arrhythmias.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Drug Discovery

Background:

  • Developing effective antiarrhythmic agents is crucial for managing cardiac arrhythmias.
  • Existing in vitro methods for drug screening can be complex or lack comprehensive characterization.
  • A need exists for a simple, reliable method to identify and characterize potential antiarrhythmic drugs.

Purpose of the Study:

  • To develop and validate a simple, nonmicroelectrode in vitro method for identifying and characterizing potential antiarrhythmic agents.
  • To assess the effects of known antiarrhythmic drugs on developed tension, excitability, and effective refractory period.
  • To establish the utility of this method for drug discovery and preclinical evaluation.

Main Methods:

  • Isolated right ventricular guinea pig papillary muscles were used.

Related Experiment Videos

  • Standard antiarrhythmic agents from classifications I, III, and IV were tested.
  • Measurements included developed tension (DT), excitability (EX), and effective refractory period (ERP) using paired field stimuli.

    • Main Results:

    • Disopyramide phosphate, sotalol, clofilium phosphate, and N-acetyl procainamide hydrochloride significantly prolonged ERP.
    • Disopyramide phosphate and verapamil significantly decreased developed tension.
    • Only disopyramide phosphate decreased excitability.
    • Results correlated well with existing literature, validating the method.

    Conclusions:

    • The developed in vitro method is effective for identifying and characterizing potential antiarrhythmic agents.
    • The method provides a simple yet comprehensive approach to assess drug effects on key electrophysiological and mechanical parameters.
    • This technique supports the preclinical screening and development of novel antiarrhythmic therapies.